Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
VA Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, Michigan, USA.
Inflamm Bowel Dis. 2019 Nov 14;25(12):1939-1944. doi: 10.1093/ibd/izz069.
Intraabdominal abscess management decisions in the treatment of Crohn disease (CD) can be challenging. Our aim was to determine the effect of clinical, medication use, and imaging disease characteristics on the need for future surgical management.
A retrospective chart review was performed in patients with CD hospitalized for abscess confirmed by imaging between 2008 and 2016. Selection criteria included nonoperative management with intravenous antibiotics at the index hospitalization and a minimum of 2 years of follow up. Demographic, disease, and medication history were extracted from electronic medical records. Radiographic disease features were assessed by an expert abdominal radiologist, blinded to clinical data. The primary outcome was resection of the bowel segment involving the abscess within 2 years of index hospitalization. Cox proportional hazards regression and statistical methods were performed using SAS 9.4.
Of the 121 patients meeting the selection criteria, 36.4% avoided surgery after 2 years of follow up. On adjusted multivariable analysis, disease-activity factors including bowel wall thickness (HR 3.08, 95% CL 1.20-6.21), disease length (HR 2.67, 95% CL 1.40-6.20), bowel dilation (HR 2.19, 95% CL 1.02-4.68), and abscess size of greater than 6 cm (HR 2.47, 95%CL 1.17-5.21) were independent risk factors for future surgery in patients not undergoing immediate bowel resection for abscess management. Biologic use and percutaneous drainage were not risk factors for ultimate surgical management.
Radiographic CD features and abscess size over 6 cm are predictors of ultimately requiring bowel resection. Radiographic measures may help stratify patients to immediate surgery or conservative management for intraabdominal CD-related abscesses.
在克罗恩病(CD)的治疗中,腹腔脓肿的管理决策具有挑战性。我们的目的是确定临床、药物使用和影像学疾病特征对未来手术管理的需求的影响。
对 2008 年至 2016 年间因影像学证实脓肿而住院的 CD 患者进行回顾性病历审查。选择标准包括在索引住院期间接受静脉抗生素的非手术治疗,并且至少有 2 年的随访。从电子病历中提取人口统计学、疾病和药物使用史。放射学疾病特征由一位腹部放射学专家评估,专家对临床数据不知情。主要结局是在索引住院后 2 年内切除涉及脓肿的肠段。使用 SAS 9.4 进行 Cox 比例风险回归和统计分析。
在符合选择标准的 121 名患者中,36.4%的患者在 2 年的随访后避免了手术。在调整后的多变量分析中,包括肠壁厚度(HR 3.08,95%CL 1.20-6.21)、疾病长度(HR 2.67,95%CL 1.40-6.20)、肠扩张(HR 2.19,95%CL 1.02-4.68)和脓肿大小大于 6cm(HR 2.47,95%CL 1.17-5.21)在内的疾病活动因素是未立即进行肠切除脓肿管理的患者未来手术的独立危险因素。生物制剂的使用和经皮引流不是最终手术管理的危险因素。
CD 的影像学特征和大于 6cm 的脓肿大小是需要最终进行肠切除术的预测因素。影像学指标可以帮助分层患者,以确定对腹腔 CD 相关脓肿进行立即手术或保守管理。